Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Register Now for the Targeted Therapies Patient Forum
Have a chance to talk with the doctors about the newest information in targeted therapies. Some potential topics our faculty will be discussing include:
NGS: Current Status, Barriers and Emerging Targets
Liquid Biopsies as a New Option: How Does it Fit In?
What is the Role for Rebiopsy Today?
Presentations by Lung Cancer Subtypes - ALK, ROS1, EGFR, RET,MET, BRAF
Immunotherapy for Targeted Therapies - What Do We Know?
Controlling the Brain as a Separate Compartment
Online Communities - Support, Education & Partnership on Research
and time for discussion and Q&A
(**subject to change)

Please feel free to offer comments and raise questions in our
discussion forums.
Hi app.92, Welcome to Grace. I'm sorry this is late getting to you. And more sorry your mum is going through this. It's possible this isn't a pancoast tumor even though...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.